178 related articles for article (PubMed ID: 27998070)
81. Amorphous solid dispersion studies of camptothecin-cyclodextrin inclusion complexes in PEG 6000.
Fatmi S; Bournine L; Iguer-Ouada M; Lahiani-Skiba M; Bouchal F; Skiba M
Acta Pol Pharm; 2015; 72(1):179-92. PubMed ID: 25850214
[TBL] [Abstract][Full Text] [Related]
82. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
83. Near-infrared light triggered release of molecules from supramolecular hydrogel-nanorod composites.
Highley CB; Kim M; Lee D; Burdick JA
Nanomedicine (Lond); 2016 Jun; 11(12):1579-90. PubMed ID: 27176049
[TBL] [Abstract][Full Text] [Related]
84. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells.
Acevedo-Morantes CY; Acevedo-Morantes MT; Suleiman-Rosado D; Ramírez-Vick JE
Drug Deliv; 2013 Nov; 20(8):338-48. PubMed ID: 24024505
[TBL] [Abstract][Full Text] [Related]
85. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
86. Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer.
Chiang YT; Yen YW; Lo CL
Biomaterials; 2015 Aug; 61():150-61. PubMed ID: 26002788
[TBL] [Abstract][Full Text] [Related]
87. Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles.
Kim C; Kim S; Oh WK; Choi M; Jang J
Chemistry; 2012 Apr; 18(16):4902-8. PubMed ID: 22422377
[TBL] [Abstract][Full Text] [Related]
88. Preparation and characterization of poly lactide-co-glycolide nanoparticles of SN-38.
Ebrahimnejad P; Dinarvand R; Sajadi SA; Atyabi F; Ramezani F; Jaafari MR
PDA J Pharm Sci Technol; 2009; 63(6):512-20. PubMed ID: 20169857
[TBL] [Abstract][Full Text] [Related]
89. Hydroxypropyl-β-cyclodextrin-graphene oxide conjugates: Carriers for anti-cancer drugs.
Tan J; Meng N; Fan Y; Su Y; Zhang M; Xiao Y; Zhou N
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():681-7. PubMed ID: 26838897
[TBL] [Abstract][Full Text] [Related]
90. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
[TBL] [Abstract][Full Text] [Related]
91. Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma.
Householder KT; DiPerna DM; Chung EP; Wohlleb GM; Dhruv HD; Berens ME; Sirianni RW
Int J Pharm; 2015 Feb; 479(2):374-80. PubMed ID: 25562639
[TBL] [Abstract][Full Text] [Related]
92. Thermo- and pH-sensitive dendrosomes as bi-phase drug delivery systems.
Adeli M; Fard AK; Abedi F; Chegeni BK; Bani F
Nanomedicine; 2013 Nov; 9(8):1203-13. PubMed ID: 23747739
[TBL] [Abstract][Full Text] [Related]
93. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
94. Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin.
Yu H; Chen J; Liu S; Lu Q; He J; Zhou Z; Hu Y
J Control Release; 2015 Oct; 216():111-20. PubMed ID: 26282096
[TBL] [Abstract][Full Text] [Related]
95. Drug delivery function of carboxymethyl-β-cyclodextrin modified upconversion nanoparticles for adamantine phthalocyanine and their NIR-triggered cancer treatment.
Wang A; Jin W; Chen E; Zhou J; Zhou L; Wei S
Dalton Trans; 2016 Mar; 45(9):3853-62. PubMed ID: 26824705
[TBL] [Abstract][Full Text] [Related]
96. Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin.
Davis ME
Adv Drug Deliv Rev; 2009 Nov; 61(13):1189-92. PubMed ID: 19682514
[TBL] [Abstract][Full Text] [Related]
97. Encapsulation of an adamantane-doxorubicin prodrug in pH-responsive polysaccharide capsules for controlled release.
Luo GF; Xu XD; Zhang J; Yang J; Gong YH; Lei Q; Jia HZ; Li C; Zhuo RX; Zhang XZ
ACS Appl Mater Interfaces; 2012 Oct; 4(10):5317-24. PubMed ID: 23009157
[TBL] [Abstract][Full Text] [Related]
98. Camptothecin: solubility, in-vitro drug release, and effect on human red blood cells and sperm cold preservation.
Fatmi S; Taouzinet L; Skiba M; Iguer-Ouada M
Cryo Letters; 2023; 44(2):89-99. PubMed ID: 37883159
[TBL] [Abstract][Full Text] [Related]
99. Acid-activatable oxidative stress-inducing polysaccharide nanoparticles for anticancer therapy.
Yoo W; Yoo D; Hong E; Jung E; Go Y; Singh SVB; Khang G; Lee D
J Control Release; 2018 Jan; 269():235-244. PubMed ID: 29146242
[TBL] [Abstract][Full Text] [Related]
100. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy.
Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Hocine O; Maynadier M; Gallud A; Da Silva A; Mongin O; Blanchard-Desce M; Richeter S; Loock B; Maillard P; Morère A; Garcia M; Raehm L; Durand JO
Int J Pharm; 2012 Aug; 432(1-2):99-104. PubMed ID: 22569231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
